SPRITAM

Peak

levetiracetam

NDAORALTABLET, FOR SUSPENSION

Approved

Jul 2015

Lifecycle

Peak

Competitive Pressure

0/100

Clinical Trials

Clinical Trials (5)

NCT04836559Phase 2Completed

A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy

Started May 2021

110 enrolled

Focal Onset Seizures

NCT03489044Phase 2Completed

An Investigation of Levetiracetam in Alzheimer's Disease

Started Oct 2018

8 enrolled

Alzheimer DiseaseEpilepsy

NCT03340064Phase 3Completed

A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age

Started Nov 2017

38 enrolled

Partial Seizures

NCT02602860Phase 1Completed

A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers

Started Nov 2015

13 enrolled

Healthy Volunteers

NCT02201251Phase 3Completed

A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy

Started Oct 2014

63 enrolled

Epilepsy